EPISODE · Aug 14, 2023 · 13 MIN
S9 Ep18: Bhatnagar Spotlights Ongoing Uproleselan Investigations in AML
from OncLive® On Air · host OncLive® On Air
Dr Bhatnagar discusses the prior and ongoing studies evaluating the addition of uproleselan to standard-of-care regimens for patients with AML, why uproleselan could affect the treatment paradigm across AML subtypes, and the rationale for pursuing minimal residual disease negativity as a clinical end point in AML.
Embed this episode
NOW PLAYING
S9 Ep18: Bhatnagar Spotlights Ongoing Uproleselan Investigations in AML
0:00
13:41
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of OncLive® On Air?
This episode is 13 minutes long.
When was this OncLive® On Air episode published?
This episode was published on August 14, 2023.
Can I download this OncLive® On Air episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!